Wire Stories
-
26.0KCloudMile: Supercharging Malaysia�s Digital Economy on Three Fronts
AI and cloud tech leader CloudMile is empowering local organizations, leveraging Google infrastructure and nurturing local tech talent in Malaysia KUALA LUMPUR,...
-
28.1K
CloudMile: Supercharging Malaysia�s Digital Economy on Three Fronts
AI and cloud tech leader CloudMile is empowering local organizations, leveraging Google infrastructure and nurturing local tech talent in Malaysia KUALA LUMPUR,...
-
26.2KGenius Group Ltd. Announces 60.68% Revenue Growth for the Nine Months Ended September 30, 2022 and Expansion of Gross Margin on a Pro Forma Basis to 47.33%
SINGAPORE–(BUSINESS WIRE)–$GNS #GNS–Genius Group Limited (�Genius Group� or the �Company�) (NYSE American: GNS), a leading entrepreneur Edtech and education group, today announced...
-
25.1KPulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a Better Quality...
-
25.0KGenius Group Ltd. Announces 60.68% Revenue Growth for the Nine Months Ended September 30, 2022 and Expansion of Gross Margin on a Pro Forma Basis to 47.33%
SINGAPORE–(BUSINESS WIRE)–$GNS #GNS–Genius Group Limited (�Genius Group� or the �Company�) (NYSE American: GNS), a leading entrepreneur Edtech and education group, today announced...
-
29.8K
Genius Group Ltd. Announces 60.68% Revenue Growth for the Nine Months Ended September 30, 2022 and Expansion of Gross Margin on a Pro Forma Basis to 47.33%
SINGAPORE–(BUSINESS WIRE)–$GNS #GNS–Genius Group Limited (�Genius Group� or the �Company�) (NYSE American: GNS), a leading entrepreneur Edtech and education group, today announced...
-
23.8KPulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a Better Quality...
-
27.4K
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a Better Quality...
-
27.4K3D Emphasizes the Need for Substantial Board Change at Fuji Soft
Believes Fuji Soft�s Recent Commitments to Address the Company�s Issues Are a Direct Response to 3D�s Campaign Notes the Importance of Continued...
-
24.3K3D Emphasizes the Need for Substantial Board Change at Fuji Soft
Believes Fuji Soft�s Recent Commitments to Address the Company�s Issues Are a Direct Response to 3D�s Campaign Notes the Importance of Continued...
To Top